As metabolic health continues to be a crucial focus, new treatments are arising. Retatrutide, Tirzepatide, and Semaglutide represent a remarkable evolution in incretin mimetic medications. While all work to https://sparxsocial.com/story1003171/retatrutide-vs-tirzepatid-vs-semaglutide-a-direct-look